The tolerability of linezolid in the treatment of nontuberculous mycobacterial disease

被引：51
作者：
Winthrop, Kevin L. [1 ,2 ]
Ku, Jennifer H. [1 ,2 ]
Marras, Theodore K. [3 ]
Griffith, David E. [4 ]
Daley, Charles L. [5 ]
Olivier, Kenneth N. [6 ]
Aksamit, Timothy R. [7 ]
Varley, Cara D. [1 ,2 ]
Mackey, Katherine [1 ,2 ]
Prevots, D. Rebecca
机构：
[1] Oregon Hlth & Sci Univ, Div Infect Dis, Portland, OR 97239 USA
[2] Oregon Hlth & Sci Univ, Div Publ Hlth & Prevent Med, Portland, OR 97239 USA
[3] Univ Toronto, Toronto, ON, Canada
[4] Univ Texas Tyler, Tyler, TX 75799 USA
[5] Natl Jewish Hlth, Denver, CO USA
[6] NIAID, Bethesda, MD 20892 USA
[7] Mayo Clin, Rochester, MN USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2015年 / 45卷 / 04期
关键词：
DRUG-RESISTANT TUBERCULOSIS; MULTIDRUG-RESISTANT; SAFETY; METAANALYSIS; EFFICACY; TB;
D O I：
10.1183/09031936.00169114
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页码：1177 / 1179
页数：3
相关论文
共 14 条
[1]   Prevalence of Nontuberculous Mycobacterial Lung Disease in US Medicare Beneficiaries [J].
Adjemian, Jennifer ;
Olivier, Kenneth N. ;
Seitz, Amy E. ;
Holland, Steven M. ;
Prevots, D. Rebecca .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2012, 185 (08) :881-886
[2]  
[Anonymous], REP TUB US 2012
[3]   Good clinical outcomes but high rates of adverse reactions during linezolid therapy for serious infections: a proposed protocol for monitoring therapy in complex patients [J].
Bishop, E ;
Melvani, S ;
Howden, BP ;
Charles, PGP ;
Grayson, ML .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (04) :1599-1602
[4]   Linezolid for the treatment of complicated drug-resistant tuberculosis: a systematic review and meta-analysis [J].
Cox, H. ;
Ford, N. .
INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2012, 16 (04) :447-454
[5]   In vitro activity of linezolid, clarithromycin and moxifloxacin against clinical isolates of Mycobacterium kansasii [J].
Guna, R ;
Muñoz, C ;
Domínguez, V ;
García-García, A ;
Gálvez, J ;
de Julián-Ortiz, JV ;
Borrás, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2005, 55 (06) :950-953
[6]   Daily 300 mg dose of linezolid for multidrug-resistant and extensively drug-resistant tuberculosis: updated analysis of 51 patients [J].
Koh, Won-Jung ;
Kang, Yeh Rim ;
Jeon, Kyeonman ;
Kwon, O. Jung ;
Lyu, Jiwon ;
Kim, Woo Sung ;
Shim, Tae Sun .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2012, 67 (06) :1503-1507
[7]   Linezolid for Treatment of Chronic Extensively Drug-Resistant Tuberculosis [J].
Lee, Myungsun ;
Lee, Jongseok ;
Carroll, Matthew W. ;
Choi, Hongjo ;
Min, Seonyeong ;
Song, Taeksun ;
Via, Laura E. ;
Goldfeder, Lisa C. ;
Kang, Eunhwa ;
Jin, Boyoung ;
Park, Hyeeun ;
Kwak, Hyunkyung ;
Kim, Hyunchul ;
Jeon, Han-Seung ;
Jeong, Ina ;
Joh, Joon Sung ;
Chen, Ray Y. ;
Olivier, Kenneth N. ;
Shaw, Pamela A. ;
Follmann, Dean ;
Song, Sun Dae ;
Lee, Jong-Koo ;
Lee, Dukhyoung ;
Kim, Cheon Tae ;
Dartois, Veronique ;
Park, Seung-Kyu ;
Cho, Sang-Nae ;
Barry, Clifton E., III .
NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (16) :1508-1518
[8]   A retrospective TBNET assessment of linezolid safety, tolerability and efficacy in multidrug-resistant tuberculosis [J].
Migliori, G. B. ;
Eker, B. ;
Richardson, M. D. ;
Sotgiu, G. ;
Zellweger, J. -P. ;
Skrahina, A. ;
Ortmann, J. ;
Girardi, E. ;
Hoffmann, H. ;
Besozzi, G. ;
Bevilacqua, N. ;
Kirsten, D. ;
Centis, R. ;
Lange, C. .
EUROPEAN RESPIRATORY JOURNAL, 2009, 34 (02) :387-393
[9]   In vitro effect of three-drug combinations of antituberculous agents against multidrug-resistant Mycobacterium tuberculosis isolates [J].
Rey-Jurado, Emma ;
Tudo, Griselda ;
Puig de la Bellacasa, Jorge ;
Espasa, Mateu ;
Gonzalez-Martin, Julian .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 41 (03) :278-280
[10]   Linezolid in the Treatment of Multidrug-Resistant Tuberculosis [J].
Schecter, G. F. ;
Scott, C. ;
True, L. ;
Raftery, A. ;
Flood, J. ;
Mase, S. .
CLINICAL INFECTIOUS DISEASES, 2010, 50 (01) :49-55
12